Colored Genetic Code DNA Molecule Structure

Inside Our Program
Seminars & Events
Biotech Nexus

Friday, April 22, 2022

Each year Northwestern’s Master of Biotechnology Program hosts Biotech Nexus, an exciting evening event which benefits both the MBP students and the biotechnology industry alike. Whether your goal is to network, define a career trajectory, recruit, become a mentor or mentee, or simply enjoy an evening among friends from the biotechnology industry, this event will help you make the right connections.

The 2022 Biotech Nexus Agenda

Welcome address, MBP director Danielle Tullman-Ercek
Explore your career potential as you become acquainted with the numerous and varied career options – both in and out of a laboratory setting – available to those with experience and education in biotechnology.

Panel discussion and Q&A
Engage with a panel of six of the industry’s leading professionals as they explore the future of their respective fields and what led them on their individual career paths. Moderated by Joshua Leonard, director of Northwestern's Biotechnology Training Program.

Networking / cocktail reception
End the evening with lively conversations and introductions during the networking reception with MBP students, alumni, faculty and industry guests.

Panel Participants at the 2022 Biotech Nexus Event


Joshua Leonard, PhD

Charles Deering McCormick Professor of Teaching Excellence, Associate Professor of Chemical and Biological Engineering, Northwestern University

Leonard trained in chemical engineering, receiving a B.S. from Stanford University in 2000, and a Ph.D. from the University of California, Berkeley in 2006. Leonard then trained as a postdoctoral fellow at the Experimental Immunology Branch of the National Cancer Institute, and he joined the faculty of Northwestern University in 2008. Leonard’s research group engineers novel biological systems that perform customized, sophisticated functions for applications in biotechnology and medicine. Leonard is an early pioneer in mammalian synthetic biology, and employing methods ranging from biomolecular engineering to computation-driven design, his group develops technologies including programmable cell-based “devices” for treating cancer and novel gene therapy platforms based upon bioengineered nanoscale vesicles. Leonard is actively engaged in the development of national science policy, testifying as an expert witness before the U.S. House of Representatives on “21st Century Biology” and through his role as a council member of the Engineering Biology Research Consortium. He fosters training, entrepreneurship, and industrial impact as director of both Northwestern’s NIH-funded Biotechnology Training Program (T32) and a graduate cluster in Biotechnology. Dr. Leonard is a founding member of Northwestern’s Center for Synthetic Biology.


Felicia Bogdan, PhD

Principal Research Scientist, Abbott Laboratories

Felicia Bogdan is a Principal Research Scientist at Abbott Laboratories where she leads a team of scientist responsible for developing biologic reagents used in blood screening assays for Transfusion Medicine. In her 20-year tenure in Abbott Diagnostics R&D, she developed organic and bioconjugate reagents for over 20 in-vitro diagnostic tests, collaborating with multidisciplinary R&D and Manufacturing teams. Felicia is co-founder of W-STEM, an Abbott employee network connecting and elevating Abbott women in STEM and providing programs to inspire young minds in the community to embrace STEM careers. Felicia earned a PhD in Organic Chemistry from Wayne State University, and a Bachelor of Science degree in Chemistry and Physics Education in Romania. She completed a postdoctoral fellowship at Northwestern University McCormick School of Engineering. Felicia enjoys listening to music, dancing, bike riding, rollerblading, and watching TEDMED talks.

Emily Hoffman, PhD

Manager, Ambit Consulting Services (ACS)

Emily Hoffman is a Manager at Ambit Consulting Services (ACS), a firm focused on the future of biopharma. Emily started in life sciences consulting after her PhD, working at both small and large corporate firms before starting at ACS. She earned her PhD at Northwestern University in Materials Science and bachelors at Case Western Reserve University in Biomedical Engineering. During her PhD, Emily was supported by the NDSEG fellowship, participated in the BTP Cluster program, completed the Kellogg ‘Management for Scientists and Engineers’ program, helped found ComSciCon-Chi, and served as a science policy Mirzayan Fellow at the National Academy of Engineering. Currently, Emily volunteers with the Society of Women Engineers, leading the annual conference research programs, and with Bike New York, teaching children and adults to learn to ride bicycles. Emily is from the Midwest and now lives in Brooklyn, New York.

Jamie Kasuboski, PhD

Vice President, OMX Ventures

Jamie Kasuboski is Vice President at OMX Ventures has more than ten years of life science sector experience, including venture capital investing, company formation, and biotech/pharma research and development roles. While with OMX Ventures, he has led investments in Type 6, Glyphic Biotechnologies, Fleet Therapeutics, and ReAx biotechnologies. Jamie previously worked at RA Capital as a senior member in their Venture investing group. Before joining RA Capital, he was a Director at Boehringer Ingelheim’s Venture Fund, focused on early-stage therapeutics investing. From 2014-to 2018, Jamie was a postdoctoral researcher in Pfizer’s Neuroscience Unit, focused on neurodegeneration research. Before joining Pfizer, Jamie was a postdoctoral researcher in James Fitzpatrick’s lab at the Waitts Biophotonics Center at the Salk Institute for Biological Studies. He designed and built experimental microscopes for neuropsychiatric screening. Jamie received a Ph.D. in Cellular and Molecular Biology from the University of Notre Dame, where he studied the role cancer kinases play in cell division. He also holds a Bachelor of Science from Hillsdale College and was an alternate captain on Hillsdale College Ice Hockey Team.

Bhavin Patel, MS

Process Engineering, Pfizer, Inc.

Bhavin Patel attended undergrad at UC Santa Cruz and has a bachelor's in Neuroscience. As an undergrad, Bhavin worked in multiple research labs studying virology/cell biology, neural synapse formation, and biogeochemistry. After graduating, he began working in a cancer biology lab at the UC DAVIS MIND Institute. Bhavin studied the effects oncogenes have on skeletal and cardiac muscle development. Before attending Northwestern, he was a Project Manager at Sequetech overseeing Biopharma client projects in North/South America. Bhavin received his master's in Biotechnology with a minor in Entrepreneurship. He completed his graduate research at Pfizer, where he worked as a Program Management Intern in the Extractables and Leachables (E&L) group. Bhavin is currently in a two-year rotational program at Pfizer in Rocky Mount, NC. His first rotation has been in Process Engineering on the packaging lines overseeing Automated Visual Inspection (AVI) projects. Soon he will be rotating into a Project Manager OpEx role overseeing continuous improvement (CI) projects.

Stephanie Pulliam, PhD

Marketing Manager, AbbVie

Stephanie Pulliam is a biomedical scientist with research experience in oncology. Her work focused on the regulation of chemotactic and inflammatory cytokines in the tumor microenvironment. She also assisted a biotechnology startup elucidate the mechanism of action for a novel anti-inflammatory peptide. To complement her scientific competency, Stephanie has business experience in sales, business development and marketing. Her experiences include a marketing role at DePuy Synthes; consultant for the Small Business Development Center; and a sales representative for 10x Genomics. In her current role as a Marketing Manager at AbbVie, Stephanie is responsible for partnering cross-functionally to develop marketing strategies for multiple pipeline molecules in both solid tumors and hematological malignancies. Stephanie enjoys exploring the world of fashion through her love of sewing. Additionally, she mentors undergraduate and graduate students on the intricacies of post-graduate life. Stephanie is looking forward to safely continuing her global trek.

Jessica Tam, MS

Senior Global Product Manager, Patient Monitoring Marketing, Baxter

Jessica Tam is a Senior Global Product Manager in Baxter’s Patient Monitoring marketing team working on new product development. Prior to joining the Patient Monitoring group, Jessica most recently led strategy and competitive intelligence for Baxter’s global Digital Health group. Jessica joined Baxter in 2017 through the Technical Development Program where she held multiple roles in innovation and R&D. She has also helped to drive several business development and licensing activities for Baxter and led the implementation of the Stanford Biodesign innovation process across the company. Jessica holds a bachelor’s degree in Chemical Engineering from Stanford University and is currently pursuing her MBA at the University of Chicago Booth School of Business in the evening part-time program.

MBP wishes to thank Northwestern’s Biotechnology Training Program for their generous support and contributions to this event.